drugset / Trial / NCT00902057
Desmopressin for Bleeding Related to Low Body Temperature
RandomizedParallel-groupTriple-blindTreatment
Summary
To study, with a prospective randomised controlled design, whether the subcutaneous administration of the haemostatic drug desmopressin, may improve the impairment of primary haemostasis due to mildly decreased temperature.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-12
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Desmopressin | Peptide | 1.5 ug | Subcutaneous |
| Comparator | Desmopressin | Peptide | 3 ug | Subcutaneous |
| Comparator | Desmopressin | Peptide | 15 ug | Subcutaneous |
Indications
No indication recorded.